Bank of America
IRWD icon

Bank of America’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bank of America’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-119,400
Closed -$1.91M – 7359
2018
Q2 		$1.91M Sell
119,400
-88,356
-43% -$1.31M ﹤0.01% 4012
2018
Q1 		$2.69M Buy
207,756
+119,400
+135% +$1.49M ﹤0.01% 3646
2017
Q4 		$1.11M Sell
88,356
-1,194
-1% -$15.6K ﹤0.01% 4418
2017
Q3 		$1.18M Hold
89,550
– – ﹤0.01% 4394
2017
Q2 		$1.42M Buy
+89,550
New +$1.3M ﹤0.01% 4183
2014
Q4 		– Sell
-2,030
Closed -$22K – 7802
2014
Q3 		$22K Buy
2,030
+1,433
+240% +$16.4K ﹤0.01% 6986
2014
Q2 		$8K Sell
597
-597
-50% -$6.49K ﹤0.01% 7537
2014
Q1 		$12K Buy
+1,194
New +$13.4K ﹤0.01% 7129

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America's IRWD Position: Q1 2026 in Review

Bank of America reduced its Ironwood Pharmaceuticals (IRWD) stake by 25% in Q1 2026, selling an estimated $11.6M and leaving 8,682,907 shares worth $30.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Bank of America first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.8M in Q4 2025. 227 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Bank of America held 8,682,907 shares of Ironwood Pharmaceuticals worth $30.5M as of Q1 2026.
  • Bank of America sold 2,838,753 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $11.6M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2021 holding.
  • Bank of America first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Ironwood Pharmaceuticals position peaked at $38.8M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.